Search Results - "KANTER, Julie"

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease by Vichinsky, Elliott, Hoppe, Carolyn C, Ataga, Kenneth I, Ware, Russell E, Nduba, Videlis, El-Beshlawy, Amal, Hassab, Hoda, Achebe, Maureen M, Alkindi, Salam, Brown, R. Clark, Diuguid, David L, Telfer, Paul, Tsitsikas, Dimitris A, Elghandour, Ashraf, Gordeuk, Victor R, Kanter, Julie, Abboud, Miguel R, Lehrer-Graiwer, Joshua, Tonda, Margaret, Intondi, Allison, Tong, Barbara, Howard, Jo

“…In a trial evaluating two daily-dose levels of voxelotor, which binds to sickle hemoglobin and prevents polymerization under hypoxic conditions, hemoglobin…”
Get full text

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease by Kanter, Julie, Walters, Mark C, Krishnamurti, Lakshmanan, Mapara, Markus Y, Kwiatkowski, Janet L, Rifkin-Zenenberg, Stacey, Aygun, Banu, Kasow, Kimberly A, Pierciey, Francis J, Bonner, Melissa, Miller, Alex, Zhang, Xinyan, Lynch, Jessie, Kim, Dennis, Ribeil, Jean-Antoine, Asmal, Mohammed, Goyal, Sunita, Thompson, Alexis A, Tisdale, John F

“…An unprespecified interim analysis of results from a phase 1–2 study of gene therapy for sickle cell disease shows resolution of severe vaso-occlusive events…”
Get full text

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease by Ataga, Kenneth I, Kutlar, Abdullah, Kanter, Julie, Liles, Darla, Cancado, Rodolfo, Friedrisch, João, Guthrie, Troy H, Knight-Madden, Jennifer, Alvarez, Ofelia A, Gordeuk, Victor R, Gualandro, Sandra, Colella, Marina P, Smith, Wally R, Rollins, Scott A, Stocker, Jonathan W, Rother, Russell P

“…In this yearlong trial involving patients with sickle cell disease, crizanlizumab, an antibody to P-selectin, was associated with a 45% lower rate of pain…”
Get full text

Challenges to Management of Pain in Sickle Cell Disease by Kanter, Julie

“…Sickle Cell Disease (SCD) is one of the most common blood disorders in the world. Pain is the primary reason for which individuals with SCD interact with the…”
Get full text

Perspectives of individuals with sickle cell disease on barriers to care by Phillips, Shannon, Chen, Yumei, Masese, Rita, Noisette, Laurence, Jordan, Kasey, Jacobs, Sara, Hsu, Lewis L, Melvin, Cathy L, Treadwell, Marsha, Shah, Nirmish, Tanabe, Paula, Kanter, Julie

“…Sickle cell disease (SCD) is an inherited hemoglobinopathy that predominantly affects African Americans in the United States. The disease is associated with…”
Get full text

Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab by Marsh, Rebecca A., Allen, Carl E., McClain, Kenneth L., Weinstein, Joanna L., Kanter, Julie, Skiles, Jodi, Lee, Nadine D., Khan, Shakila P., Lawrence, Julia, Mo, Jun Q., Bleesing, Jack J., Filipovich, Alexandra H., Jordan, Michael B.

“…Background Hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome that remains difficult to treat. Even with current…”
Get full text

Current and novel therapies for the prevention of vaso-occlusive crisis in sickle cell disease by Osunkwo, Ifeyinwa, Manwani, Deepa, Kanter, Julie

“…Individuals with sickle cell disease (SCD) are living further into adulthood in high-resource countries. However, despite increased quantity of life,…”
Get full text

Density-based separation in multiphase systems provides a simple method to identify sickle cell disease by Kumar, Ashok A., Patton, Matthew R., Hennek, Jonathan W., Lee, Si Yi Ryan, D'Alesio-Spina, Gaetana, Yang, Xiaoxi, Kanter, Julie, Shevkoplyas, Sergey S., Brugnara, Carlo, Whitesides, George M.

“…Significance Red blood cells with a high density (ρ > 1.120 g/cm ³) are characteristic of sickle cell disease. This paper demonstrates a density-based…”
Get full text

Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study by Kanter, Julie, Thompson, Alexis A., Pierciey, Francis J., Hsieh, Matthew, Uchida, Naoya, Leboulch, Philippe, Schmidt, Manfred, Bonner, Melissa, Guo, Ruiting, Miller, Alex, Ribeil, Jean‐Antoine, Davidson, David, Asmal, Mohammed, Walters, Mark C., Tisdale, John F.

“…lovo‐cel (bb1111; LentiGlobin for sickle cell disease [SCD]) gene therapy (GT) comprises autologous transplantation of hematopoietic stem and progenitor cells…”
Get full text

Factors associated with left ventricular hypertrophy in children with sickle cell disease; results from the DISPLACE study by Galadanci, Najibah A, Johnson, Walter, Carson, April, Hellemann, Gerhard, Howard, Virginia, Kanter, Julie

“…Cardiopulmonary complications remain a leading cause of morbidity and mortality in sickle cell disease (SCD). The overall goals of this study were to evaluate…”
Get full text

Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium by Masese, Rita V, Bulgin, Dominique, Knisely, Mitchell R, Preiss, Liliana, Stevenson, Eleanor, Hankins, Jane S, Treadwell, Marsha J, King, Allison A, Gordeuk, Victor R, Kanter, Julie, Gibson, Robert, Glassberg, Jeffrey A, Tanabe, Paula, Shah, Nirmish

“…Sex-based clinical outcome differences in sickle cell disease (SCD) remain largely unknown despite evidence that female sex is associated with an increased…”
Get full text

48847 Assessing Transition Outcomes in Sickle Cell Disease (SCD) Prior To Implementation of A Formal Transition Program by Sheppard, Sydney, Kanter, Julie

“…ABSTRACT IMPACT: To identify potential facilitators and barriers to a successful transition in care. OBJECTIVES/GOALS: Improvements in care for children with…”
Get full text

Current Methods of Newborn Screening Follow-Up for Sickle Cell Disease Are Highly Variable and without Quality Assurance: Results from the ENHANCE Study by Galadanci, Najibah, Phillips, Shannon, Schlenz, Alyssa, Ivankova, Nataliya, Kanter, Julie

“…Newborn screening (NBS) for sickle cell disease (SCD) has significantly improved childhood survival but there are still gaps resulting in delayed care for…”
Get full text

Simple paper-based test for measuring blood hemoglobin concentration in resource-limited settings by Yang, Xiaoxi, Piety, Nathaniel Z, Vignes, Seth M, Benton, Melody S, Kanter, Julie, Shevkoplyas, Sergey S

“…The measurement of hemoglobin concentration ([Hb]) is performed routinely as a part of a complete blood cell count to evaluate the oxygen-carrying capacity of…”
Get full text

Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry by Glassberg, Jeffrey A, Linton, Elizabeth A, Burson, Katrina, Hendershot, Tabitha, Telfair, Joseph, Kanter, Julie, Gordeuk, Victor R, King, Allison A, Melvin, Cathy L, Shah, Nirmish, Hankins, Jane S, Epié, Axel Yannick, Richardson, Lynne D

“…Sickle cell disease (SCD) is an autosomal recessive blood disorder affecting approximately 100,000 Americans and 3.1 million people globally. The scarcity of…”
Get full text

Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA by Smeltzer, Matthew P, Howell, Kristen E, Treadwell, Marsha, Preiss, Liliana, King, Allison A, Glassberg, Jeffrey A, Tanabe, Paula, Badawy, Sherif M, DiMartino, Lisa, Gibson, Robert, Kanter, Julie, Klesges, Lisa M, Hankins, Jane S

“…ObjectivesSickle cell disease (SCD) leads to chronic and acute complications that require specialised care to manage symptoms and optimise clinical results…”
Get full text

Validation of a Low-Cost Paper-Based Screening Test for Sickle Cell Anemia by Piety, Nathaniel Z, Yang, Xiaoxi, Kanter, Julie, Vignes, Seth M, George, Alex, Shevkoplyas, Sergey S

“…The high childhood mortality and life-long complications associated with sickle cell anemia (SCA) in developing countries could be significantly reduced with…”
Get full text

Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry by Mendez, Gustavo G, Nocek, Judith M, Brambilla, Donald J, Jacobs, Sara, Cole, Oladipo, Kanter, Julie, Glassberg, Jeffrey, Saving, Kay L, Melvin, Cathy L, Gibson, Robert W, Treadwell, Marsha, Jackson, George L, King, Allison A, Gordeuk, Victor R, Kroner, Barbara, Hsu, Lewis L

“…Adults with sickle cell disease (SCD) suffer early mortality and high morbidity. Many are not affiliated with SCD centers, defined as no ambulatory visit with…”
Get full text

PB2524: TRIAL IN PROGRESS: THE HIBISCUS‐KIDS STUDY, A SINGLE‐ARM, OPEN‐LABEL, PHASE 1/2 STUDY TO EVALUATE THE PHARMACOKINETICS AND SAFETY OF ETAVOPIVAT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE by Colombatti, Raffaella, Kanter, Julie, Wu, Eric, Clay, Leila J., Campbell, Andrew

Get full text

Association Between Patent Foramen Ovale and Overt Ischemic Stroke in Children With Sickle Cell Disease by Galadanci, Najibah A, Johnson, Walter, Carson, April, Hellemann, Gerhard, Howard, Virginia, Kanter, Julie

“…Ischemic stroke is one of the most devastating complications of sickle cell anemia (SCA). Previous studies have shown that intracardiac shunting including…”
Get full text